-
Chinese Medicine Innovation Dragon Hair Wei! 3 exclusive proprietary Chinese medicines sold tens
Time of Update: 2022-09-21
In recent years, China's three major terminals and 6 major markets lianhua qing plague sales (: 10,000 yuan) Source: Intranet Database Tongxinluo Capsules, Ginsengsong Yangxin Capsules, and Qiqi Qiangxin Capsules are the three major fist products of Ling Pharmaceutical in the field of cardiovascular chinese patent medicine, and they are all exclusive, national medical insurance Class A, national basic drug species, and the "main battlefield" is in the hospital market (public hospital + public primary medical care).
-
Chinese Medicine Innovation Dragon Hair Wei! 3 exclusive proprietary Chinese medicines sold for 10 billion
Time of Update: 2022-09-20
2019H1-2022H1 R&D investment of Yiling Pharmaceutical (: 100 million yuan) Source: Company Announcement Since 2020, 16 new Chinese medicine drugs (in terms of drug name + enterprise, excluding APIs) have been approved for listing, covering anti-tumor, respiratory system, nervous system, gynecology, orthopedics and other therapeutic fields.
-
The first new First-in-Class drug is expected to solve the problem of hair loss in 700 million
Time of Update: 2020-08-30
In addition to the hair-making project, Tecoro Bio has expanded its dermatology research area, developing new drugs in the fields of dermatitis eczema, psoriasis, spot baldness, nail disease and scarring, and has made good progress.
-
Development of innovative hair loss therapy El Jian reached research and development cooperation
Time of Update: 2020-06-07
Nucleic acid drugs play a therapeutic role by targeting potentially pathogenic genes However, reducing toxicity and effective delivery of drugs are the biggest technical challenges in the development
-
Middle-aged male gospel? Hair loss innovative drug companies go to Hong Kong listing, income 0 yuan valuation of billions
Time of Update: 2020-05-15
Guide: Hair loss special effects medicine, hundreds of billions of market restructuring is the beginning Another innovative pharmaceutical company went to Hong Kong to list May 12, Pioneering Pharm
-
Development of hair loss innovative therapy and R & D cooperation reached by Erjian
Time of Update: 2019-11-18
Recently, exicure announced that it has signed a global cooperation agreement with Allergan The two companies will develop two new treatments for hair loss by using the special 3D spherical nucleic ac
-
R & D daily to develop hair loss innovative therapy Erjian has reached R & D cooperation
Time of Update: 2019-11-18
Jardiance is better than DPP-4 inhibitor and GLP-1 receptor agonist in reducing the risk of heart failure in Hospital; Sansheng pharmaceutical is authorized by PSGL-1 monoclonal antibody, a new target
-
The first year of science and Technology Innovation Board: the entanglement between the rise
Time of Update: 2019-11-05
Science and technology innovation board is about to usher in its first anniversary In November 5th last year, President Xi Jinping announced the establishment of a scientific innovation board and a pi